What is the emergency management of acute respiratory failure, including airway protection, oxygen supplementation, criteria for non‑invasive ventilation versus intubation, ventilator settings, and treatment of the underlying cause?

Emergency Management of Acute Respiratory Failure

Immediately assess airway patency, initiate controlled oxygen therapy targeting SpO₂ 94-98% (or 88-92% if hypercapnia suspected), obtain arterial blood gas within 60 minutes, and start non-invasive ventilation when pH <7.35 with PaCO₂ >6.0 kPa despite optimal medical treatment. 1, 2, 3

Immediate Airway Assessment and Protection

Positioning and Basic Airway Maneuvers

• Place conscious patients in semi-recumbent position (head elevated 30-45°) to reduce aspiration risk and improve ventilation mechanics 1
• Position unconscious patients laterally and insert oro- or nasopharyngeal airway if needed to maintain patency 1
• Perform oral hygiene and suction oropharyngeal secretions repetitively to prevent aspiration pneumonia 1

Absolute Contraindications to Non-Invasive Ventilation (Requiring Immediate Intubation)

• Recent facial/upper airway surgery, facial burns or trauma 2
• Fixed upper airway obstruction 2
• Active vomiting or recent upper gastrointestinal surgery 2
• Inability to protect airway or copious respiratory secretions 1, 2
• Respiratory arrest or peri-arrest state 4
• Hemodynamic instability or decreased consciousness 1, 4

Oxygen Supplementation Strategy

Type 1 (Hypoxemic) Respiratory Failure

• Target SpO₂ 94-98% in patients without risk of hypercapnia 3
• Start with high-flow oxygen or standard oxygen therapy while obtaining arterial blood gas 3
• Consider high-flow nasal oxygen (HFNO) as first-line for de novo acute hypoxemic respiratory failure, as it reduces intubation rates with significant mortality reduction (absolute risk difference -15.8%) 2, 3

Type 2 (Hypercapnic) Respiratory Failure

• Target SpO₂ 88-92% to avoid worsening hypercapnia 1, 3
• In known COPD patients ≥50 years, start controlled oxygen ≤28% via Venturi mask (or 2 L/min nasal cannula) before arterial blood gas results 3
• Never administer high-flow uncontrolled oxygen without confirming absence of hypercapnia—this precipitates CO₂ narcosis and respiratory arrest 3, 4
• Repeat arterial blood gas 60 minutes after any oxygen adjustment 3
• Drive nebulizers with compressed air, not oxygen, when hypercapnia present 3

Arterial Blood Gas Analysis: Critical Decision Points

Timing and Interpretation

• Obtain arterial blood gas within 60 minutes of presentation in any patient with acute breathlessness, recording FiO₂ 1, 3
• Measure again 30-60 minutes after oxygen initiation to detect rising PaCO₂ or falling pH 3
• Low threshold for arterial blood gas in neuromuscular disease, chest wall deformity, obesity, or confusion—these patients develop respiratory failure without significant dyspnea 1

NIV Initiation Thresholds

• pH <7.35 AND PaCO₂ >6.0 kPa (45 mmHg) after optimal medical treatment = start NIV immediately 1, 2, 3
• pH 7.30-7.35: manage on respiratory ward with close monitoring 2
• pH <7.30: transfer to HDU/ICU for NIV initiation 2
• pH <7.26 predicts poor outcome and imminent respiratory arrest—prepare for intubation 3

Non-Invasive Ventilation vs. Intubation Decision Algorithm

Strong Indications for NIV (Level A Evidence)

• COPD exacerbation with respiratory acidosis (pH <7.35, PaCO₂ >6.0 kPa) despite maximal medical treatment—reduces mortality 46% and intubation 65% 1, 2, 5
• Cardiogenic pulmonary edema unresponsive to CPAP 1
• Hypercapnic respiratory failure from chest wall deformity or neuromuscular disease 1, 4
• Facilitating extubation in COPD patients 1, 5

Weaker Evidence for NIV (Consider with Caution)

• Decompensated obstructive sleep apnea with respiratory acidosis 1
• Immunocompromised patients with acute respiratory failure 5
• Pneumonia or ARDS: trial only in HDU/ICU setting with immediate intubation capability—NIV failure is independent mortality risk factor 1, 3
• Do NOT use routinely in acute asthma 1

NIV Setup Protocol (Bi-Level Pressure Support)

Initial Settings for COPD/Hypercapnic Failure:

• IPAP: 10-12 cmH₂O (start lower, titrate up) 3
• EPAP: 4-5 cmH₂O 3, 4
• Backup rate: 15-25 breaths/min 4
• Use full-face mask initially, switch to nasal after 24 hours 1, 2

For Neuromuscular Disease (e.g., Duchenne):

• Use controlled ventilation mode (pressure-control), NOT pressure-support—trigger sensitivity poor in neuromuscular disease 4
• IPAP: 12-20 cmH₂O (8-12 cmH₂O if no skeletal deformity) 4
• EPAP: 4-5 cmH₂O (increase if bulbar dysfunction) 4
• I:E ratio: 1:1 4
• Start mechanical insufflator-exsufflator immediately for secretion clearance 4

NIV Monitoring and Failure Criteria

Reassess at 1-2 Hours:

• Repeat arterial blood gas on optimal settings 1, 2
• If pH and PaCO₂ worsen or fail to improve: proceed to intubation 1, 2, 4
• If modest improvement: continue NIV, repeat gas at 4-6 hours 1, 2
• If no improvement in pH/PaCO₂ by 4-6 hours: intubate 1, 2

Continuous Monitoring Requirements:

• Pulse oximetry, respiratory rate, heart rate, conscious level, patient comfort 2
• Clinical assessment for increased work of breathing, accessory muscle use, paradoxical breathing 2

Invasive Mechanical Ventilation

Immediate Intubation Indications

• Respiratory or cardiac arrest 4
• Severe hemodynamic instability 1
• Impaired consciousness (GCS <8) 1
• Inability to clear secretions despite airway clearance techniques 4
• NIV failure by above criteria 1, 2
• Severe life-threatening hypoxemia unresponsive to NIV/HFNO 1

Lung-Protective Ventilation Settings (Mandatory for ALL Intubated Patients)

• Tidal volume: 6 mL/kg predicted body weight 1, 3, 6, 7
• Plateau pressure: <30 cmH₂O 1, 3
• Peak pressure (pressure-control mode): <30 cmH₂O 1
• Adequate PEEP level (individualized) 1
• Reduce FiO₂ to <60% as soon as possible after intubation 6
• Prefer spontaneous breathing modes when feasible 1

Special Considerations for ARDS (Moderate-to-Severe)

• High-level PEEP (weakly recommended) 7
• Prone positioning for prolonged periods (12-16 hours/day) strongly recommended for severe ARDS 7
• Consider neuromuscular blockade for refractory hypoxemia 6
• Restrictive fluid strategy in absence of shock 7

Treatment of Underlying Cause

COPD Exacerbation

• Nebulized bronchodilators immediately on arrival 3
  • Moderate: salbutamol 2.5-5 mg OR ipratropium 0.25-0.5 mg every 4-6 hours 3
  • Severe: combine salbutamol AND ipratropium 3
• Systemic corticosteroids for 7-14 days (prednisolone 30 mg/day PO or hydrocortisone 100 mg IV) 3
• Antibiotics when sputum frankly purulent: amoxicillin or tetracycline first-line; broad-spectrum cephalosporin or newer macrolide for severe cases 3

Cardiogenic Pulmonary Edema

• CPAP first-line for hypoxemia—dramatically effective with diuresis and preload reduction 1, 3
• Reserve NIV for patients who fail CPAP 1

Sepsis-Related Respiratory Failure

• Antimicrobials within 1 hour of recognizing sepsis—each hour delay decreases survival 7.6% 1
• Early mechanical ventilation (NIV or invasive) for increased work of breathing and/or persistent hypoxemia despite oxygen 1

Neuromuscular Disease (Duchenne, ALS, Myasthenia)

• NIV is initial treatment during respiratory infections 3, 4
• Aggressive airway clearance with mechanical insufflator-exsufflator 4
• Admit to HDU/ICU—standard ward monitoring insufficient 4
• Contact specialist respiratory and neuromuscular teams immediately 4

Critical Pitfalls to Avoid

• Delaying intubation when NIV clearly failing—respiratory deterioration may result in cardiac arrest 2
• Administering high-flow oxygen without arterial blood gas in suspected Type 2 failure 3, 4
• Using pressure-support triggering in neuromuscular disease—controlled ventilation required 4
• Relying on pulse oximetry alone when respiratory acidosis present—serial arterial blood gases mandatory 3
• Starting NIV on general ward in patients with pH <7.30 2
• Neglecting secretion clearance in neuromuscular patients—key determinant of NIV success 4
• Normalizing oxygen saturation in Type 2 failure—worsens hypercapnia 3, 4

Service Organization Requirements

• NIV facilities available 24 hours/day in all hospitals admitting acute respiratory failure 1, 2
• Trained nursing staff capable of initiating and maintaining NIV 1
• Clear protocols for on-call staff: indications, initiation, supervision responsibility 1
• Respiratory physician involvement as soon as possible 1
• Single ventilator model per clinical area for staff familiarity 1